SOURCE: NaturalNano, Inc.

August 20, 2013 10:00 ET

NaturalNano Announces Second Quarter Financial Results; Sales Revenues Show Significant Increase of 680% Based on Fiabila

ROCHESTER, NY--(Marketwired - Aug 20, 2013) - NaturalNano, Inc. (OTCQB: NNAN) ( announced today financial results for the Second Quarter. During the second quarter, NNAN sales line increased 680% compared to second quarter in 2012 led by increased sales growth in NaturalNano's patented Halloysite Nanotube (HNT) products.

CEO James Wemett said, "NaturalNano's HNT business made steady progress during the quarter driven by our continued collaboration with Fiabila S.A. to supply HNT for their nail polish products. Also, we continue to work to establish new uses for HNT, particularly with biomedical applications for HNT. We continue to support the experimental work of Dr. Michael King, at Cornell University, who has published a study demonstrating that HNT improved the surface performance of a prototype cell capturing device."

Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.

Contact Information